ExodusPoint Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
ExodusPoint Capital Management's NVO Position: Q1 2026 in Review
ExodusPoint Capital Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 274,272 shares — an estimated $14M sold.
ExodusPoint Capital Management first reported a position in NVO in Q2 2019 and held it in 14 quarters. The position peaked at $19.4M in Q2 2022. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- ExodusPoint Capital Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
- ExodusPoint Capital Management sold 274,272 Novo Nordisk shares in Q1 2026, an estimated $14M.
- ExodusPoint Capital Management first reported a position in Novo Nordisk in Q2 2019 and held it in 14 quarters.
- ExodusPoint Capital Management's Novo Nordisk position peaked at $19.4M in Q2 2022.
- 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.